Related Experiment Video

Updated: Mar 6, 2026

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

2.1K

Future strategies for the discovery of therapeutic aptamers

Sorah Yoon1, John J Rossi1,2

  • 1a Department of Molecular and Cellular Biology , Beckman Research Institute of City of Hope , Duarte , CA , USA.

Expert Opinion on Drug Discovery
|March 10, 2017
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Future strategieschemical modificationmutant antigensprecision medicinetheranostic aptamers

More Related Videos

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

7.2K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K

Related Experiment Videos

Last Updated: Mar 6, 2026

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

2.1K
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

7.2K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K

Articles linked to this work by shared authors, journal, and citation graph.

Revisiting long-standing biological questions through evolving technologies.

Bioscience trends·2026

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026

C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy.

Science (New York, N.Y.)·2025

Small RNAs as therapeutic agents: From catalytic motifs to regulatory pathways.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.

Cell reports. Medicine·2025

Tumor spheroids versus organoids: defining the more suitable three-dimensional model for cancer research.

Expert opinion on drug discovery·2026

Challenges in modeling interstitial cystitis: implications for drug discovery efforts.

Expert opinion on drug discovery·2026

Advances in the emerging field of epi-informatics in drug discovery: roads taken and future prospects.

Expert opinion on drug discovery·2026

Bioengineered In vitro bone marrow models of acute myeloid leukemia for novel drug discovery.

Expert opinion on drug discovery·2026

Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10-2474 and the challenges ahead.

Expert opinion on drug discovery·2026

Models of depression for preclinical drug discovery and development: an update of the literature.

Expert opinion on drug discovery·2026

Optimizing Immunohistochemical Detection of Matriglycan in Muscles of Dystroglycanopathy.

Applied immunohistochemistry & molecular morphology : AIMM·2026

Human organoids and organ-on-chip systems for AI-guided therapeutic discovery against emerging and re-emerging infections.

Frontiers in pharmacology·2026

Breaking Biological Barriers: Engineering Nanocarriers for Efficient Drug and Gene Delivery through Nano-Bio Interfaces and Biophysical Design.

Applied physics reviews·2026

Cystine Containing Cationic Amphiphilic Peptide-Based Injectable, Noncytotoxic, Proteolytically Stable Hydrogel with Anti-infective Surface-Coating Activity against Multidrug-Resistant Bacterial and Fungal Biofilms.

ACS applied bio materials·2026

Solid-state nanopore and nanochannel platforms for biomarker detection in disease diagnosis: recent advances and perspectives.

Nanoscale·2026

Artificial Intelligence-Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us